You need to enable JavaScript to run this app.
Recon: US pays $1.95B for Pfizer, BioNTech COVID-19 vaccine; Biogen lifts forecast on Tecfidera sales
Recon
Michael Mezher
ReconMichael Mezher
ReconMichael Mezher